Syndax Pharmaceuticals Inc

SNDXNASDAQ · USD
18.24USD0.00 (+2.10%)
127

Syndax Pharmaceuticals Inc (SNDX) Unusual Options Activity Today

SNDX options volume power reached 5x on the previous trading day. The highest reading was on the $18 CALL expiring 2026-11-20.

Read more

Checking SNDX unusual options activity helps you spot when traders are making outsized bets on Syndax Pharmaceuticals Inc before the broader market catches on. Syndax Pharmaceuticals Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor SNDX unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching SNDX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking SNDX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and SNDX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat.

It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.Massachusetts.

Catalysts rarely arrive without a footprint, and SNDX unusual options activity is often where that footprint shows up first. Our scanner tracks Syndax Pharmaceuticals Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at SNDX unusual options volume on the call side or chasing put sweeps, Syndax Pharmaceuticals Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
18.000.751.100.9362%51729.41%
25.000.050.250.15103%2512,33210.76%
20.000.050.600.3364%22660.75%
10.005.8010.007.90123%010.00%
11.004.908.406.6529%00—
Puts
20.001.853.702.7890%21020.00%
16.000.050.450.2560%1156.67%
10.00—0.100.10161%00—
11.00—0.150.15152%010.00%
12.00—0.150.15129%01260.00%

As of September 29, 2026

Spot unusual options activity before it moves

Track SNDX options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial